AVBP: ArriVent BioPharma, Inc.
Performance
AVBP -21.53%
Watchlist
Select an item
Summary
AVBP at a glance
AVBP returned -21.53% over the past year. Its worst drop in that year was -64.80%, smaller than 9% of stocks on Redstone, and its Sharpe ratio of 0.14 beats 33% of stocks on Redstone. It pays no dividends.
Current Drawdown
-59.24%
Rolling Volatility
126.09%
Actions
Metrics
Risk Indicators
Alpha-0.20%
Beta1.15x
Sharpe0.14
Sortino0.17
Omega1.03
Calmar-0.33
Martin0.56
Profile
About AVBP
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $698M
- Listed
- Jan 2024
- Employees
- 77
- Headquarters
- Newtown Square, PA
- Website
- arrivent.com
Comparisons